526 related articles for article (PubMed ID: 30374838)
21. Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.
Li R; Wang C; Liu L; Du C; Cao S; Yu J; Wang SE; Hao X; Ren X; Li H
Cancer Immunol Immunother; 2012 Nov; 61(11):2125-33. PubMed ID: 22581306
[TBL] [Abstract][Full Text] [Related]
22. Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.
Qiao G; Wang X; Zhou L; Zhou X; Song Y; Wang S; Zhao L; Morse MA; Hobeika A; Song J; Yi X; Xia X; Ren J; Lyerly HK
Clin Cancer Res; 2019 Mar; 25(5):1494-1504. PubMed ID: 30514775
[TBL] [Abstract][Full Text] [Related]
23. Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences.
Ren J; Di L; Song G; Yu J; Jia J; Zhu Y; Yan Y; Jiang H; Liang X; Che L; Zhang J; Wan F; Wang X; Zhou X; Lyerly HK
Clin Transl Oncol; 2013 Oct; 15(10):780-8. PubMed ID: 23359185
[TBL] [Abstract][Full Text] [Related]
24. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
[TBL] [Abstract][Full Text] [Related]
25. Adoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancer.
Wang M; Cao JX; Pan JH; Liu YS; Xu BL; Li D; Zhang XY; Li JL; Liu JL; Wang HB; Wang ZX
PLoS One; 2014; 9(11):e112662. PubMed ID: 25412106
[TBL] [Abstract][Full Text] [Related]
26. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Han RX; Liu X; Pan P; Jia YJ; Yu JC
PLoS One; 2014; 9(9):e108958. PubMed ID: 25268709
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
Wu C; Jiang J; Shi L; Xu N
Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
[TBL] [Abstract][Full Text] [Related]
29. Impact of cellular immune function on prognosis of lung cancer patients after cytokine-induced killer cell therapy.
Jin C; Li J; Wang Y; Chen X; Che Y; Liu X; Wang X; Sriplung H
Asian Pac J Cancer Prev; 2014; 15(15):6009-14. PubMed ID: 25124565
[TBL] [Abstract][Full Text] [Related]
30. Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis.
Wang ZX; Cao JX; Liu ZP; Cui YX; Li CY; Li D; Zhang XY; Liu JL; Li JL
World J Gastroenterol; 2014 Jan; 20(4):1095-106. PubMed ID: 24574784
[TBL] [Abstract][Full Text] [Related]
31. Effect of maintenance therapy with dendritic cells: cytokine-induced killer cells in patients with advanced non-small cell lung cancer.
Shi SB; Ma TH; Li CH; Tang XY
Tumori; 2012; 98(3):314-9. PubMed ID: 22825506
[TBL] [Abstract][Full Text] [Related]
32. Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis.
Wang ZX; Cao JX; Wang M; Li D; Cui YX; Zhang XY; Liu JL; Li JL
Cytotherapy; 2014 Jul; 16(7):934-45. PubMed ID: 24794183
[TBL] [Abstract][Full Text] [Related]
33. Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy.
Yang D; Wang X; Zhou X; Zhao J; Yang H; Wang S; Morse MA; Wu J; Yuan Y; Li S; Hobeika A; Lyerly HK; Ren J
Oncoimmunology; 2021; 10(1):1976953. PubMed ID: 34595059
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer.
Zhong R; Teng J; Han B; Zhong H
Cancer Immunol Immunother; 2011 Oct; 60(10):1497-502. PubMed ID: 21681372
[TBL] [Abstract][Full Text] [Related]
35. Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy.
Mai HX; Mei GH; Zhao FL; Li BT; Tang YY; Zhang B; Xu XJ; Chen LJ
J Cancer Res Ther; 2018 Jun; 14(Supplement):S427-S432. PubMed ID: 29970701
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy analysis of Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with Paclitaxel-Cisplatin Chemotherapy in patients with Advanced Ovarian Cancer.
Gao Y; Hao Y; Jia Y
J BUON; 2021; 26(2):553-560. PubMed ID: 34077005
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I-II non-small cell lung cancer after curative surgery.
Huang J; Zhao X; Zhang Z; Yang S; Chen X; Shen C; Wang L; Qi Y; Zhang Y
Cytotherapy; 2023 Feb; 25(2):202-209. PubMed ID: 36379882
[TBL] [Abstract][Full Text] [Related]
39. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis.
He G; Zheng C; Huo H; Zhang H; Zhu Z; Li J; Zhang H
Int Immunopharmacol; 2016 Nov; 40():436-442. PubMed ID: 27716591
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study.
Luo H; Gong L; Zhu B; Huang Y; Tang C; Yu S; Yang Z; Zhou X
Biomed Pharmacother; 2016 Dec; 84():987-993. PubMed ID: 27764762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]